Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers: A Comparison of Outcomes in Patients With COVID-19

Circ Cardiovasc Qual Outcomes. 2020 Oct;13(10):e007115. doi: 10.1161/CIRCOUTCOMES.120.007115. Epub 2020 Aug 28.

¹ Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute (A.K., J.S., M.K.C.), Cleveland Clinic, OH.
² Section of Cardiovascular Research, Heart, Vascular and Thoracic Department, Cleveland Clinic Akron General, OH (A.K.).
³ Center for Emergency Medicine-West, Cleveland Clinic Medina Hospital, Medina, OH (E.S.H.).
⁴ Department of Quantitative Health Sciences, Lerner Research Institute (A.S.N., A.M.), Cleveland Clinic, OH.
⁵ Department of Internal Medicine, Cleveland Clinic Foundation, OH (V.J.).
⁶ Department of Nephrology and Hypertension (G.T.), Cleveland Clinic, OH.
⁷ Department of Nephrology and Hypertension, Cleveland Clinic Florida, Weston, FL (S.K.G.).
⁸ Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute (S.S.K., M.K.C.), Cleveland Clinic, OH.
⁹ Cleveland Clinic Foundation, OH (L.J.).
¹⁰ Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University (J.B.Y., N.M.), Cleveland Clinic, OH.
¹¹ Department of Thoracic and Cardiovascular Surgery, Heart, Vascular and Thoracic Institute (L.G.S.), Cleveland Clinic, OH.

No abstract available

Keywords: COVID-19; mechanical ventilation; pandemic; propensity score; upregulation.

Publication types